#LUS#L regulator to rule on pain drug #LUS#L food and drug regulators will decide on Friday whether to recommend the sale of painkillers that have been linked to a high risk of heart attack and stroke .
He went on to say that things have since changed in the light of new reports .
Given this new information  its is not clear that the cardiovascular risk observed in Approve makes Vioxx unique in the class of similar drugs marketed in the #LUS#L   Mr Kim explained .

ained .


